Search - tctmd.com

Displaying 321 - 336 of 336

Sort: Relevancy | Date

Presentation TVT 2013

Defining and Measuring Frailty in Aortic Stenosis Patients: From the Eyeball Test to Objective Tools

Presenter: Philip Green

June 12, 2013

News Daily News

Meta-analysis: Disease Prevalence, Number of TAVR Candidates Growing

Yael L. Maxwell

May 31, 2013

News Daily News

Tumor Marker Predicts TAVR Outcomes

May 29, 2013

News Conference News EuroPCR 2013

Deflection Device Reduces Volume, Not Number, of Cerebral Lesions During TAVR

Jason Kahn

May 24, 2013

News Daily News

Persistent LBBB After CoreValve Implantation Associated With Need for Pacemaker

February 28, 2013

News Daily News

El BRIHH Persistente tras la Implantación de un Dispositivo CoreValve se asoció a la Necesidad de tener que Implantar un Marcapaso

February 28, 2013

Presentation

Clinical Impact of Persistent LBBB After TAVR with CoreValve Revalving System

Presenter: 127662|Luca Testa

February 27, 2013

News Daily News

Study Explores Predictors, Consequences of Stroke After TAVR

Caitlin E. Cox

November 18, 2012

News Daily News

Un Estudio Explora los Predictores y Consecuencias de los ACV tras una TAVR

Caitlin E. Cox

November 18, 2012

Presentation TCT 2012

The European TAVR “Test Track”: After 5 Years, Have TAVR Use Patterns Drifted Out of Control?

Presenter: Nicolo Piazza

October 25, 2012

Presentation TCT 2012

“Asymptomatic” Severe Aortic Stenosis: Use of Exercise Testing, Watchful Waiting vs. Early Valve Replacement

Presenter: Blase Carabello

October 22, 2012

News Conference News ESC 2012

Registries Show Strides for Transcatheter Valve Treatments in Europe

Caitlin E. Cox

August 27, 2012

News Daily News

Cerebral Embolization During TAVR Comparable Across Access Routes, Devices

August 24, 2012

News Daily News

TAVR Use Outstrips Evidence in Europe, BMJ Analysis Says

August 02, 2012

Advertisement

Defining and Measuring Frailty in Aortic Stenosis Patients: From the Eyeball Test to Objective Tools

Meta-analysis: Disease Prevalence, Number of TAVR Candidates Growing

Tumor Marker Predicts TAVR Outcomes

Deflection Device Reduces Volume, Not Number, of Cerebral Lesions During TAVR

Persistent LBBB After CoreValve Implantation Associated With Need for Pacemaker

El BRIHH Persistente tras la Implantación de un Dispositivo CoreValve se asoció a la Necesidad de tener que Implantar un Marcapaso

Clinical Impact of Persistent LBBB After TAVR with CoreValve Revalving System

Study Explores Predictors, Consequences of Stroke After TAVR

Un Estudio Explora los Predictores y Consecuencias de los ACV tras una TAVR

The European TAVR “Test Track”: After 5 Years, Have TAVR Use Patterns Drifted Out of Control?

“Asymptomatic” Severe Aortic Stenosis: Use of Exercise Testing, Watchful Waiting vs. Early Valve Replacement

Registries Show Strides for Transcatheter Valve Treatments in Europe

Cerebral Embolization During TAVR Comparable Across Access Routes, Devices

TAVR Use Outstrips Evidence in Europe, BMJ Analysis Says

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content